Vascepa is a prescription medication that contains the active ingredient icosapent ethyl, which is a type of omega-3 fatty acid. It is used to reduce triglyceride levels in adults with severe hypertriglyceridemia, which is a condition characterized by high levels of triglycerides in the blood. Vascepa is a relatively new medication that was approved by the FDA in 2012 [1].
According to a study published in the Journal of Clinical Lipidology, Vascepa has been shown to be effective in reducing triglyceride levels in patients with hypertriglyceridemia [2]. The study found that patients who took Vascepa experienced a significant reduction in triglyceride levels compared to those who took a placebo. Additionally, Vascepa was found to be well-tolerated by patients, with few adverse side effects reported [2].
Compared to other long-term treatments for hypertriglyceridemia, Vascepa has several advantages. For example, it is a relatively new medication, which means that it has been subject to more recent clinical trials and research studies than some other treatments. Additionally, Vascepa is a prescription medication, which means that it is only available through a healthcare provider. This can help ensure that patients receive appropriate medical supervision and monitoring while taking the medication [3].
However, like all medications, Vascepa has potential side effects. According to Medical News Today, some of the most common side effects of Vascepa include joint pain, swelling, and stiffness, as well as gastrointestinal symptoms such as diarrhea, nausea, and upset stomach [3]. It is important for patients to discuss any potential side effects with their healthcare provider before starting treatment with Vascepa.
In summary, Vascepa is a prescription medication that has been shown to be effective in reducing triglyceride levels in patients with hypertriglyceridemia. While it has several advantages over other long-term treatments, such as being a relatively new medication and requiring medical supervision, it is important for patients to be aware of potential side effects and to discuss any concerns with their healthcare provider [1][2][3].
Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671468/
[3] https://www.medicalnewstoday.com/articles/drugs-vascepa-side-effects